On a mis­sion to make or­gan trans­plants safer and more durable, Black­stone gifts Ta­laris a new CEO, leads $100M round

As a trans­plant sur­geon by train­ing, Suzanne Ild­stad un­der­stood the plight of her pa­tients all too well: The risk of or­gan re­jec­tion forces them to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.